Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$1.31 - $2.69 $4,748 - $9,751
-3,625 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$4.12 - $5.87 $100,186 - $142,740
-24,317 Reduced 87.03%
3,625 $16,000
Q1 2021

May 14, 2021

BUY
$3.45 - $9.09 $96,399 - $253,992
27,942 New
27,942 $164,000
Q1 2020

May 13, 2020

SELL
$1.8 - $4.28 $62,956 - $149,697
-34,976 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$3.16 - $5.15 $110,524 - $180,126
34,976 New
34,976 $145,000
Q4 2018

Feb 13, 2019

SELL
$6.15 - $10.51 $52,951 - $90,491
-8,610 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$10.32 - $13.06 $88,855 - $112,446
8,610 New
8,610 $91,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $134M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.